Correction: Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice

Citation: The PLOS ONE Staff (2014) Correction: Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1a in db/db Mice. PLoS ONE 9(8): e105921. doi:10.1371/journal.pone.0105921 Correction: Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1a in db/db Mice The PLOS ONE Staff sentence should read: In total, 20 mg/kg/day of fenofibrate was administered to the treated db/db and db/m groups. There are errors in the sixth sentence of the second paragraph of the Discussion. The corrected sentence should read: Recently, we demonstrated that the AMPK activator resveratrol improves lipotoxicity in the kidney by enhancing the PPARa-ERR-1aSREBP-1-mediated removal of lipid accumulation and decreasing apoptotic renal cell death and oxidative stress related to FoxO3a dephosphorylation in diabetic nephropathy. 1. Hong YA , Lim JH , Kim MY , Kim TW , Kim Y , et al. ( 2014 ) Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1a in db/db Mice . PLoS ONE 9 ( 5 ) : e96147 . doi:10.1371/journal.pone. 0096147 (...truncated)